I.M. Markusse

491 citations

24 papers · 354 indexed · h-index 9

Impact in

Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 10%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 23
- Rheumatoid Arthritis Research and Therapies 22
- Systemic Lupus Erythematosus Research 6
- Musculoskeletal synovial abnormalities and treatments 3
Pathology and Forensic Medicine 9
- Lymphoma Diagnosis and Treatment 8

Co-authors: T. Huizinga (20 shared papers)Cornelia F Allaart (15 shared papers)Willem F. Lems (17 shared papers)P. J. S. M. Kerstens (13 shared papers)Linda Dirven (13 shared papers)H. K. Ronday (9 shared papers)J.H.L.M. van Groenendael (4 shared papers)Andreas Gerards (1 shared paper)
Journals: Annals of the Rheumatic Diseases (4 papers)RMD Open (3 papers)Clinical Rheumatology (3 papers)Annals of Internal Medicine (2 papers)Lara D. Veeken (2 papers)
Partner nations: Netherlands United States Italy

In The Last Decade

I.M. Markusse

23 papers receiving 351 citations

Peers

Countries citing papers authored by I.M. Markusse

Since Specialization

Citations

This map shows the geographic impact of I.M. Markusse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I.M. Markusse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I.M. Markusse more than expected).

Fields of papers citing papers by I.M. Markusse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I.M. Markusse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I.M. Markusse. The network helps show where I.M. Markusse may publish in the future.

Co-authors

The 25 scholars most cited alongside I.M. Markusse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with I.M. Markusse Line = papers co-authored together I.M. Markusse links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment Annals of Internal Medicine ·I.M. Markusse, G. Akdemir, Linda Dirven, Yvonne P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, K. Huub Han, T.H.E. Molenaar, Saskia le Cessie, Willem F. Lems, Peter A. H. M. van der Lubbe, P. J. S. M. Kerstens, André J. Peeters, H. K. Ronday, P. B. J. de Sonnaville, I. Speyer, Theo Stijnen, S. ten Wolde, T. Huizinga, Cornelia F Allaart	2016	87
2	Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study Arthritis Research & Therapy ·I.M. Markusse, Linda Dirven, Andreas Gerards, J.H.L.M. van Groenendael, H. K. Ronday, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2015	85
3	Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies Lara D. Veeken ·I.M. Markusse, J. Meijs, B. de Boer, Jaap Bakker, H. Schippers, Anne A. Schouffoer, Nina Ajmone Marsan, Lucia J.M. Kroft, Maarten K. Ninaber, T. Huizinga, Jeska K de Vries‐Bouwstra	2016	53
4	A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study The Journal of Rheumatology ·I.M. Markusse, Linda Dirven, Marianne van den Broek, C. Bijkerk, K. Huub Han, H. K. Ronday, Rebecca Bolce, Eric H. Sasso, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2014	32
5	Evaluating Adherence to a Treat‐to‐Target Protocol in Recent‐Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation Arthritis Care & Research ·I.M. Markusse, Linda Dirven, K. H. Han, H. K. Ronday, P. B. J. de Sonnaville, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2015	20
6	Drug-free holiday in patients with rheumatoid arthritis: a qualitative study to explore patients’ opinion Clinical Rheumatology ·I.M. Markusse, G. Akdemir, T. Huizinga, Cornelia F Allaart	2014	13
7	Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis RMD Open ·G. Akdemir, I.M. Markusse, Sytske Anne Bergstra, Robbert J Goekoop, Esmeralda T. H. Molenaar, J.H.L.M. van Groenendael, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2018	10
8	Continued Participation in a Ten‐Year Tight Control Treat‐to‐Target Study in Rheumatoid Arthritis: Why Keep Patients Doing their Best? Arthritis Care & Research ·I.M. Markusse, Linda Dirven, K. Huub Han, H. K. Ronday, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2015	10
9	Rheumatologists’ adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission Clinical Rheumatology ·G. Akdemir, I.M. Markusse, Y P M Goekoop-Ruiterman, Gerda M. Steup‐Beekman, Bernard Grillet, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2016	9
10	Mortality in a Large Cohort of Patients with Early Rheumatoid Arthritis That Were Treated-to-Target for 10 Years. Data Archiving and Networked Services (DANS) ·I.M. Markusse, Linda Dirven, J.H. van Groenendael, K. H. Han, H. K. Ronday, P.J.S.M. Kerstens, W.F. Lems, T. Huizinga, C.F. Allaart	2014	6
11	Linear extrapolation of missing radiographic change scores in clinical trials does not spuriously overestimate group radiographic changes in rheumatoid arthritis Lara D. Veeken ·I.M. Markusse, Robert Landewé, Ron Wolterbeek, Meilien Ho, Martin Jenkins, Désirée van der Heijde	2016	6
12	Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis Arthritis Research & Therapy ·I.M. Markusse, Jeska K de Vries‐Bouwstra, K. Huub Han, Peter AHM van der Lubbe, Anne A. Schouffoer, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2014	4
13	What have we learned from BeSt? Clinical Immunology ·Cornelia F Allaart, I.M. Markusse, Willem F. Lems	2017	3
14	An unusual causative pathogen of sepsis after a cat bite: Anaerobiospirillum succiniciproducens. PubMed ·I.M. Markusse, S. P. van Mens, Peter J. de Vries	2018	3
15	Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment Annals of Internal Medicine ·I.M. Markusse, G. Akdemir, Linda Dirven, Yvonne P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, K. Huub Han, T.H.E. Molenaar, Saskia le Cessie, Willem F. Lems, Peter A. H. M. van der Lubbe, P. J. S. M. Kerstens, André J. Peeters, H. K. Ronday, P. B. J. de Sonnaville, I. Speyer, Theo Stijnen, S. ten Wolde, T. Huizinga, Cornelia F Allaart	2016	2
16	Age affects joint space narrowing in patients with early active rheumatoid arthritis RMD Open ·X. Matthijssen, G. Akdemir, I.M. Markusse, T. Stijnen, N. Riyazi, K. H. Han, C. Bijkerk, P. J. S. M. Kerstens, Willem F. Lems, T. Huizinga, Cornelia F Allaart	2016	2
17	Erosions in the foot at baseline are predictive of orthopaedic shoe use after 10 years of treat to target therapy in patients with recent onset rheumatoid arthritis Clinical Rheumatology ·Sytske Anne Bergstra, I.M. Markusse, G. Akdemir, H. K. Ronday, K. Huub Han, Willem F. Lems, P. J. S. M. Kerstens, Rosaline van den Berg, Robert Landewé, Cornelia F Allaart	2015	2
18	THU0259 10 Years of Treat-To-Target Therapy in Rheumatoid Arthritis Patients (The Best Study): Clinical and Radiographic Outcomes Annals of the Rheumatic Diseases ·I.M. Markusse, Linda Dirven, M. vd Broek, G. Akdemir, Y P M Goekoop-Ruiterman, H. Han, P. Kerstens, Willem F. Lems, T. Huizinga, C.F. Allaart	2014	2
19	Assessment of Two Different DAS Treatment Targets in Early Active Rheumatoid Arthritis Patients Data Archiving and Networked Services (DANS) ·G. Akdemir, I.M. Markusse, Y P M Goekoop-Ruiterman, J.B. Harbers, M. van Oosterhout, P. J. S. M. Kerstens, W.F. Lems, T. Huizinga, C.F. Allaart	2016	1
20	THU0257 Acpa-Negative RA Patients Benefit from Initial Combination Therapy with Early Clinical Improvement - A Sub-Analysis of the Best Study Annals of the Rheumatic Diseases ·G. Akdemir, I.M. Markusse, Linda Dirven, Maries van den Broek, E. Molenaar, Anne A. Schouffoer, P. Kerstens, W.F. Lems, T. Huizinga, C.F. Allaart	2014	1

About I.M. Markusse

I.M. Markusse is a scholar working on Rheumatology, Pathology and Forensic Medicine, Genetics, Radiology, Nuclear Medicine and Imaging and Statistics and Probability, having authored 24 papers that have together received 354 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Systemic Lupus Erythematosus Research (6 papers), Musculoskeletal synovial abnormalities and treatments (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Statistical Methods in Clinical Trials (3 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Rheumatology (276 citations), Hematology (88 citations), Pathology and Forensic Medicine (115 citations), Genetics (62 citations) and Immunology (60 citations). I.M. Markusse has collaborated with scholars based in Netherlands, United States and Italy. Frequent co-authors include T. Huizinga, Cornelia F Allaart, Willem F. Lems, P. J. S. M. Kerstens, Linda Dirven, H. K. Ronday, J.H.L.M. van Groenendael, Andreas Gerards, P. B. J. de Sonnaville and Saskia le Cessie. Their work appears in journals such as Annals of the Rheumatic Diseases, RMD Open, Clinical Rheumatology, Annals of Internal Medicine and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact